Paradigm Biopharmaceuticals Limited (P86.F) Q1 2026 Earnings

26FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.03
-0.02
-0.02
-0.01

Details

Expected EPS
N/A
Actual EPS
-0.031774033974
Surprise EPS
-0.03
Surprise Percent
+∞%

Description

Paradigm Biopharmaceuticals Limited (P86.F) has reported earnings of -0.031774033974 per share for Q1 2026.

0 Comments

Share your thoughts